MENU
+Compare
PRQR
Stock ticker: NASDAQ
AS OF
May 8 closing price
Price
$1.55
Change
-$0.02 (-1.27%)
Capitalization
165.18M

PRQR ProQR Therapeutics NV Forecast, Technical & Fundamental Analysis

ProQR Therapeutics NV is a biopharmaceutical company... Show more

Industry: #Biotechnology
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for PRQR with price predictions
May 07, 2025

PRQR in upward trend: 10-day moving average crossed above 50-day moving average on May 06, 2025

The 10-day moving average for PRQR crossed bullishly above the 50-day moving average on May 06, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 21, 2025. You may want to consider a long position or call options on PRQR as a result. In of 110 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PRQR just turned positive on April 14, 2025. Looking at past instances where PRQR's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where PRQR advanced for three days, in of 214 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for PRQR moved out of overbought territory on May 05, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 54 cases where PRQR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

PRQR moved below its 50-day moving average on May 06, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRQR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PRQR broke above its upper Bollinger Band on May 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PRQR entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.637) is normal, around the industry mean (14.238). P/E Ratio (0.000) is within average values for comparable stocks, (62.770). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.866). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (6.274) is also within normal values, averaging (252.967).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PRQR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRQR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PRQR is expected to report earnings to rise 3.11% to -9 cents per share on May 08

ProQR Therapeutics NV PRQR Stock Earnings Reports
Q1'25
Est.
$-0.09
Q4'24
Est.
$-0.09
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.09
Q1'24
Beat
by $0.01
The last earnings report on March 13 showed earnings per share of -9 cents, beating the estimate of -9 cents. With 438.60K shares outstanding, the current market capitalization sits at 165.18M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Zernikedreef 9
Phone
+31 881667000
Employees
157
Web
https://www.proqr.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPCX12.88N/A
N/A
Goldman Sachs Large Cap Equity C
VVONX20.54N/A
N/A
Invesco Value Opportunities R5
SIEPX12.91N/A
N/A
Saratoga International Equity I
DNLCX48.46N/A
N/A
BNY Mellon Active MidCap C
FWOZX16.11N/A
N/A
Fidelity Advisor Women's Leadership Z

PRQR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with KRRO. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then KRRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
-1.27%
KRRO - PRQR
61%
Loosely correlated
+10.55%
WVE - PRQR
58%
Loosely correlated
+0.77%
ATNF - PRQR
55%
Loosely correlated
-0.64%
ENVB - PRQR
43%
Loosely correlated
+4.96%
RCKT - PRQR
37%
Loosely correlated
+11.57%
More